Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,913 | 94 | 84.3% |
| Gift | $355.82 | 1 | 15.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Welch Allyn | $355.82 | 1 | $0 (2019) |
| Novo Nordisk Inc | $247.38 | 13 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $229.42 | 11 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $223.62 | 13 | $0 (2022) |
| Nevro Corp. | $214.52 | 4 | $0 (2022) |
| Merck Sharp & Dohme LLC | $133.69 | 8 | $0 (2023) |
| Daiichi Sankyo Inc. | $131.24 | 7 | $0 (2021) |
| Amgen Inc. | $111.51 | 4 | $0 (2022) |
| PFIZER INC. | $99.36 | 5 | $0 (2021) |
| Esperion Therapeutics, Inc. | $78.32 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $24.00 | 1 | Novo Nordisk Inc ($24.00) |
| 2023 | $52.58 | 3 | Merck Sharp & Dohme LLC ($20.79) |
| 2022 | $449.48 | 16 | Nevro Corp. ($214.52) |
| 2021 | $779.12 | 41 | AstraZeneca Pharmaceuticals LP ($123.47) |
| 2020 | $207.54 | 10 | Novo Nordisk Inc ($84.06) |
| 2019 | $600.59 | 14 | Welch Allyn ($355.82) |
| 2018 | $95.60 | 6 | Merck Sharp & Dohme Corporation ($28.34) |
| 2017 | $60.33 | 4 | PFIZER INC. ($26.90) |
All Payment Transactions
95 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/17/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: Diabetes | ||||||
| 12/06/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/25/2023 | Merck Sharp & Dohme LLC | STEGLATRO (Drug), VERQUVO, VERQUVO | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/12/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Diabetes | ||||||
| 09/20/2022 | Nevro Corp. | Omnia (Device) | Food and Beverage | In-kind items and services | $124.91 | General |
| Category: Spinal Cord Stimulator | ||||||
| 09/20/2022 | Nevro Corp. | Omnia (Device) | Food and Beverage | In-kind items and services | $38.05 | General |
| Category: Spinal Cord Stimulator | ||||||
| 09/20/2022 | Nevro Corp. | Omnia (Device) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Spinal Cord Stimulator | ||||||
| 09/14/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: Diabetes | ||||||
| 08/25/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Respiratory | ||||||
| 07/14/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: Respiratory | ||||||
| 06/02/2022 | Nevro Corp. | Omnia (Device) | Food and Beverage | In-kind items and services | $32.88 | General |
| Category: Spinal Cord Stimulator | ||||||
| 03/08/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: Diabetes Care | ||||||
| 02/21/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Diabetes | ||||||
| 02/17/2022 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 02/15/2022 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: Diabetes | ||||||
| 02/09/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/07/2022 | Merck Sharp & Dohme LLC | BELSOMRA (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: NEUROSCIENCE | ||||||
| 01/28/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Diabetes | ||||||
| 01/27/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: Diabetes | ||||||
| 01/18/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $26.42 | General |
| Category: Inflammation | ||||||
| 12/21/2021 | RedHill Biopharma Inc. | Talicia (Drug) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: Antibiotic | ||||||
| 12/17/2021 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $13.72 | General |
| Category: Cardiovascular | ||||||
| 12/03/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/24/2021 | PFIZER INC. | PREVNAR 13 (Biological), PREVNAR 20 | Food and Beverage | In-kind items and services | $32.41 | General |
| Category: VACCINES | ||||||
| 11/17/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 457 | 822 | $158,421 | $62,338 |
| 2022 | 32 | 1,234 | 1,530 | $181,502 | $67,255 |
| 2021 | 47 | 4,077 | 6,431 | $419,452 | $145,528 |
| 2020 | 48 | 3,461 | 4,890 | $342,232 | $124,865 |
All Medicare Procedures & Services
139 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 111 | 377 | $103,298 | $38,545 | 37.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 34 | 34 | $8,024 | $5,065 | 63.1% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 58 | 86 | $9,976 | $4,035 | 40.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 20 | 20 | $6,920 | $3,814 | 55.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 22 | 30 | $5,640 | $2,414 | 42.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $7,416 | $2,029 | 27.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 21 | 26 | $4,888 | $1,915 | 39.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 24 | 24 | $2,832 | $1,716 | 60.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 67 | 117 | $1,755 | $974.40 | 55.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 25 | 25 | $1,250 | $877.25 | 70.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 46 | 52 | $4,472 | $557.72 | 12.5% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 11 | 13 | $1,950 | $394.16 | 20.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 163 | 341 | $96,058 | $35,873 | 37.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 51 | 51 | $12,926 | $7,874 | 60.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 56 | 70 | $12,089 | $4,628 | 38.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 23 | 23 | $8,380 | $3,178 | 37.9% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 41 | 60 | $6,955 | $3,076 | 44.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 12 | 12 | $4,392 | $1,942 | 44.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 13 | 13 | $1,534 | $891.02 | 58.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 45 | 45 | $3,112 | $756.00 | 24.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 19 | 20 | $990.00 | $694.10 | 70.1% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2022 | 45 | 45 | $2,792 | $678.60 | 24.3% |
| 82746 | Folic acid level, serum | Office | 2022 | 45 | 45 | $2,723 | $661.50 | 24.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 138 | 222 | $3,330 | $653.31 | 19.6% |
| 84480 | Thyroid hormone, t3 measurement, total | Office | 2022 | 45 | 45 | $2,626 | $638.10 | 24.3% |
About Young Park
Young Park is a Family Medicine healthcare provider based in Bay Shore, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/03/2015. The National Provider Identifier (NPI) number assigned to this provider is 1083094189.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Young Park has received a total of $2,269 in payments from pharmaceutical and medical device companies, with $24.00 received in 2024. These payments were reported across 95 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($1,913).
As a Medicare-enrolled provider, Park has provided services to 9,229 Medicare beneficiaries, totaling 13,673 services with total Medicare billing of $399,986. Data is available for 4 years (2020–2023), covering 139 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Bay Shore, NY
- Active Since 06/03/2015
- Last Updated 05/18/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1083094189
Products in Payments
- Omnia (Device) $214.52
- Ozempic (Drug) $190.78
- INJECTAFER (Drug) $131.24
- FARXIGA (Drug) $130.49
- ENTRESTO (Drug) $122.29
- XOLAIR (Biological) $107.13
- NEXLETOL (Drug) $78.32
- BREZTRI (Drug) $73.23
- Livalo (Drug) $69.69
- JANUVIA (Drug) $66.45
- Aimovig (Biological) $59.46
- PREVNAR 13 (Biological) $59.01
- TRULICITY (Drug) $57.70
- Rybelsus (Drug) $56.60
- Otezla (Drug) $52.05
- DUPIXENT (Biological) $43.28
- CHANTIX (Drug) $40.35
- SUNOSI (Drug) $36.53
- RINVOQ (Biological) $29.18
- FREESTYLE LIBRE 2 (Device) $23.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Bay Shore
Dr. Louis Loiodice, Do, DO
Family Medicine — Payments: $35,044
Mrs. Carla Canavire Weber, Do, DO
Family Medicine — Payments: $20,707
Dr. Martha Pilchman, M.d, M.D
Family Medicine — Payments: $13,318
Simone Guest, D.o, D.O
Family Medicine — Payments: $13,073
Erika Hiby, M.d, M.D
Family Medicine — Payments: $3,913
Mr. Jose Rodriguez-Ospina, Md, MD
Family Medicine — Payments: $3,867